TCBP vs. TFFP, UPC, NEXI, HSTO, NAVB, SMFL, SCPS, VAXX, EVLO, and CMRA
Should you be buying TC Biopharm stock or one of its competitors? The main competitors of TC Biopharm include TFF Pharmaceuticals (TFFP), Universe Pharmaceuticals (UPC), NexImmune (NEXI), Histogen (HSTO), Navidea Biopharmaceuticals (NAVB), Smart for Life (SMFL), Scopus BioPharma (SCPS), Vaxxinity (VAXX), Evelo Biosciences (EVLO), and Comera Life Sciences (CMRA). These companies are all part of the "pharmaceutical products" industry.
TC Biopharm vs.
TFF Pharmaceuticals (NASDAQ:TFFP) and TC Biopharm (NASDAQ:TCBP) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk, community ranking and valuation.
TFF Pharmaceuticals has a beta of 1.23, suggesting that its stock price is 23% more volatile than the S&P 500. Comparatively, TC Biopharm has a beta of -0.15, suggesting that its stock price is 115% less volatile than the S&P 500.
TFF Pharmaceuticals currently has a consensus price target of $44.00, suggesting a potential upside of 67,592.31%. TC Biopharm has a consensus price target of $48.00, suggesting a potential upside of 1,820.00%. Given TFF Pharmaceuticals' higher probable upside, research analysts plainly believe TFF Pharmaceuticals is more favorable than TC Biopharm.
TC Biopharm has higher revenue and earnings than TFF Pharmaceuticals.
15.3% of TFF Pharmaceuticals shares are held by institutional investors. Comparatively, 16.3% of TC Biopharm shares are held by institutional investors. 4.5% of TFF Pharmaceuticals shares are held by company insiders. Comparatively, 15.4% of TC Biopharm shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
TFF Pharmaceuticals received 65 more outperform votes than TC Biopharm when rated by MarketBeat users. Likewise, 67.68% of users gave TFF Pharmaceuticals an outperform vote while only 66.67% of users gave TC Biopharm an outperform vote.
TC Biopharm has a net margin of 0.00% compared to TFF Pharmaceuticals' net margin of -1,596.64%. TC Biopharm's return on equity of 0.00% beat TFF Pharmaceuticals' return on equity.
In the previous week, TC Biopharm had 1 more articles in the media than TFF Pharmaceuticals. MarketBeat recorded 1 mentions for TC Biopharm and 0 mentions for TFF Pharmaceuticals. TFF Pharmaceuticals' average media sentiment score of 0.00 equaled TC Biopharm'saverage media sentiment score.
Summary
TC Biopharm beats TFF Pharmaceuticals on 8 of the 13 factors compared between the two stocks.
Get TC Biopharm News Delivered to You Automatically
Sign up to receive the latest news and ratings for TCBP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TC Biopharm Competitors List
Related Companies and Tools
This page (NASDAQ:TCBP) was last updated on 2/22/2025 by MarketBeat.com Staff
Free TCBP Stock Alerts